Meeder Asset Management Inc Alkermes Plc. Transaction History

Meeder Asset Management Inc

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	BUY	$26.4 - $30.54 $52 - $61	2 Added 2.0%	102 $3,000
Q1 2022 May 10, 2022	BUY	$23.07 - $27.99 $2,307 - $2,799	100 New	100 $3,000
Q4 2021 Feb 11, 2022	SELL	$21.47 - $32.08 $196,944 - $294,269	-9,173 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$18.78 - $25.15 $116,680 - $156,256	-6,213 Reduced 40.38%	9,173 $225,000
Q1 2021 Apr 28, 2021	BUY	$18.21 - $23.2 $278,358 - $354,635	15,286 Added 15286.0%	15,386 $286,000
Q4 2020 Feb 09, 2021	SELL	$15.39 - $22.1 $242,977 - $348,914	-15,788 Reduced 99.37%	100 $2,000
Q3 2020 Nov 02, 2020	BUY	$16.16 - $20.66 $13,897 - $17,767	860 Added 5.72%	15,888 $264,000
Q2 2020 Aug 11, 2020	SELL	$13.31 - $19.41 $44,548 - $64,965	-3,347 Reduced 18.21%	15,028 $291,000
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $65 - $106	5 Added 0.03%	18,375 $265,000
Q4 2019 Feb 13, 2020	BUY	$17.29 - $21.74 $177,793 - $223,552	10,283 Added 127.15%	18,370 $375,000
Q3 2019 Oct 17, 2019	BUY	$19.51 - $24.28 $115,850 - $144,174	5,938 Added 276.31%	8,087 $158,000
Q2 2019 Aug 05, 2019	BUY	$21.47 - $37.33 $7,278 - $12,654	339 Added 18.73%	2,149 $48,000
Q4 2018 Jan 17, 2019	BUY	$27.94 - $44.61 $30,761 - $49,115	1,101 Added 155.29%	1,810 $53,000
Q3 2018 Nov 02, 2018	SELL	$38.6 - $46.12 $14,938 - $17,848	-387 Reduced 35.31%	709 $0
Q2 2018 Jul 24, 2018	BUY	$40.56 - $51.36 $23,443 - $29,686	578 Added 111.58%	1,096 $0
Q1 2018 May 03, 2018	BUY	$53.61 - $67.26 $10,400 - $13,048	194 Added 59.88%	518 $30,000
Q4 2017 Feb 02, 2018	BUY	$47.69 - $55.39 $15,451 - $17,946	324	324 $18,000

375

166M

231K

158K

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.53B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.